Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares
AI-generated summary
Officer McCourt Marion proposed to sell 1,132 common shares with an aggregate market value of $984,194.76 through UBS Financial Services Inc. on October 30, 2026. The shares were originally acquired through an RSA vesting on December 12, 2023. The sale was made under a trading plan adopted on February 17, 2026.
Key facts
- Seller
- McCourt Marion
- Relationship
- Officer
- Shares to sell
- 1,132
- Market value
- $984,194.76
- Approximate sale date
- Oct 30, 2026
- Broker
- UBS Financial Services Inc.
- Acquired
- Dec 12, 2023 · RSA Vesting
Rule 10b5-1 plan · adopted Feb 17, 2026
More REGN filings
- 144
Filed Oct 30, 2026
- 144
Filed Oct 30, 2026
- 10-Q
Filed Oct 30, 2026
- 8-K
Filed Oct 30, 2026
- 4
Filed Oct 15, 2026
- 144
Filed Oct 14, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.